Levetiracetam in Meige's syndrome

Acta Neurol Scand. 2006 Jul;114(1):63-6. doi: 10.1111/j.1600-0404.2006.00624.x.

Abstract

The spontaneous occurrence of blepharospasm and dystonic movements in face muscles, particularly those of the perioral and mandibular regions, has been named as Meige's disease which was first described by Henry Meige in 1910. We report the case of a woman with Meige's syndrome whose symptoms improved with the use of levetiracetam.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / administration & dosage*
  • Botulinum Toxins, Type A / adverse effects
  • Brain / drug effects
  • Brain / physiopathology
  • Disorders of Excessive Somnolence / chemically induced
  • Dose-Response Relationship, Drug
  • Electromyography / drug effects
  • Facial Muscles / innervation
  • Facial Muscles / physiopathology*
  • Female
  • Humans
  • Ion Channels / drug effects
  • Ion Channels / metabolism
  • Levetiracetam
  • Meige Syndrome / diagnosis
  • Meige Syndrome / drug therapy*
  • Meige Syndrome / physiopathology
  • Middle Aged
  • Molecular Chaperones / genetics
  • Piracetam / administration & dosage
  • Piracetam / analogs & derivatives*
  • Treatment Outcome

Substances

  • Anticonvulsants
  • Ion Channels
  • Molecular Chaperones
  • TOR1A protein, human
  • Levetiracetam
  • Botulinum Toxins, Type A
  • Piracetam